Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.
Bagnasco D, Nicola S, Testino E, Brussino L, Pini L, Caminati M, Piccardo F, Canevari RF, Melissari L, Ioppi A, Guastini L, Lombardi C, Milanese M, Losa F, Robbiano M, De Ferrari L, Riccio AM, Guida G, Bonavia M, Fini D, Balbi F, Caruso C, Paggiaro P, Blasi F, Heffler E, Paoletti G, Canonica GW, Senna G, Passalacqua G, On Behalf Of Sani.
Bagnasco D, et al. Among authors: paoletti g.
Biomedicines. 2023 Aug 30;11(9):2424. doi: 10.3390/biomedicines11092424.
Biomedicines. 2023.
PMID: 37760865
Free PMC article.